Using Circulating Tumor DNA as a Novel Biomarker to Screen and Diagnose Colorectal Cancer: A Meta-Analysis

(1) Background: Circulating tumor DNA (ctDNA) has emerged as a promising biomarker for many kinds of tumors. However, whether ctDNA could be an accurate diagnostic biomarker in colorectal cancer (CRC) remains to be clarified. The aim of this study was to evaluate the diagnostic accuracy of ctDNA in...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Liang, Chen, Jinghua, Yu, Meihong, Liu, Deliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860998/
https://www.ncbi.nlm.nih.gov/pubmed/36675337
http://dx.doi.org/10.3390/jcm12020408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860998/
https://www.ncbi.nlm.nih.gov/pubmed/36675337
http://dx.doi.org/10.3390/jcm12020408

Ejemplares similares